This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Levitzky, Y. S. Articles by Fox, C. S. Search for Related Content PubMed Articles by Levitzky, Y. S. Articles by Fox, C. S. Related Collections Related Article

Impact of Impaired Fasting Glucose on Cardiovascular Disease

The Framingham Heart Study

Yamini S. Levitzky, MD^_*, Michael J. Pencina, PhD^_*,, Ralph B. D’Agostino, PhD^_*,, James B. Meigs, MD, MPH^,1, Joanne M. Murabito, MD, ScM^_*,_**, Ramachandran S. Vasan, MD^_*,||,#,2 and Caroline S. Fox, MD, MPH^_*,,,_*

^_* National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, Massachusetts
National Heart, Lung, and Blood Institute, Bethesda, Maryland
Statistics and Consulting Unit, Department of Mathematics, Boston University, Boston, Massachusetts
Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
^|| Cardiology Section, Boston University School of Medicine, Boston, Massachusetts
^# Department of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, Massachusetts
^_** Section of General Internal Medicine, Department of Medicine, Boston Medical Center, Boston, Massachusetts
Department of Endocrinology, Metabolism, and Diabetes, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts.

View larger version (8K): [in this window] [in a new window] [Download PPT slide]   Figure 1 Kaplain-Meier Plots of CVD-Free Survival by Glycemic Category CVD = cardiovascular disease; DM = diabetes mellitus; NGT = normal glucose tolerance; 100–109 = 100 to 109 mg/dl; 110–125 = 110 to 125 mg/dl.